Saudi FM and U.S. envoy to Lebanon discuss regional issues    PIF announces $7 billion inaugural Murabaha Credit Facility    Golden Globes 2025: France's 'Emilia Pérez' wins big, as 'The Brutalist' nabs major awards    Congo executes 102 'urban bandits' with 70 more set to be killed, officials say    Alabama nursing student wins Miss America 2025    New York first US city to have congestion charge    Israeli soldiers face growing risk of arrest abroad after Gaza service    Demi Moore continues comeback with Golden Globe win    Chinese nationals arrested with gold bars and $800,000 cash in DR Congo    Body of missing Indian journalist found in septic tank    Dakar and CATRION team up to elevate catering experience at Dakar Rally Saudi Arabia 2025    Projected funding needs for 2025 estimated at SR139 billion as per annual borrowing plan    60 trucks cross to Jordan in first convoy of Saudi Relief Land Bridge for Syria    Bahrain stage dramatic comeback to defeat Oman and claim Khaleeji Zain 26 title    KSrelief delegation carries out field visits to Syrian hospitals; meets UNHCR officials Saudi Arabia opens door to volunteering in over 20 medical specialties to support Syria    Elon Musk confirms Starlink application to launch internet services in Pakistan    Elm enhances brand identity by introducing 'Human, Ambition and Technology' elements The move comes as part of the company's efforts to position itself as a leader in digital landscape, further establishing KSA's presence in global digital economies    AC Milan beats Juventus 2-1 to reach Supercoppa final against Inter    Ronaldo eyes AFC Champions League glory with Al Nassr    Meghan announces new Netflix lifestyle show    Order vs. Morality: Lessons from New York's 1977 Blackout    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



EU publishes AstraZeneca contract amid coronavirus vaccine row
Published in The Saudi Gazette on 29 - 01 - 2021

The European Union published its coronavirus vaccine contract with AstraZeneca amid an ongoing row over delays to vaccine deliveries.
It came after European Commission President Ursula von der Leyen weighed in on the dispute with the pharmaceutical company, telling a German radio station on Friday that there is "no plausible explanation" for its delay in supplying its vaccine to the EU.
The European Medicines Agency is expected on Friday to authorize the use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines.
The European Commission has been locked in a dispute with the British-Swedish pharmaceutical company since it said it would deliver far smaller than expected supplies to EU member nations.
The European Union is looking at legal ways to guarantee the delivery of all the COVID-19 vaccine doses it bought from AstraZeneca and other drugmakers.
The Commission President increased the pressure on AstraZeneca in her interview, reiterating the EU's view that the contract is unambiguous and its rejection of the company's reasons for cutting planned supplies by at least 60 percent.
"There are binding orders and the contract is crystal clear," she said.
Von der Leyen dismissed the claims by AstraZeneca — which has blamed "glitches" in production — that under its contract with the EU it was only obliged to make "best efforts" to deliver supplies.
"(The phrase) 'best efforts' meant as long as it was not clear whether they (AstraZeneca) can develop a vaccine. We have now passed that time. The vaccine is here."
She added that the Commission wanted to make the contract public. Later, the Commission did just that.
"We want to publish it today," she said. "This is business sensitive data, that's clear. But basically: we want to create transparency on these issues that I have just touched on. We know exactly what is in the contract, which is why it is important to us that it is now made public."
In a sign of the level of EU mistrust in AstraZeneca, on Thursday Belgian authorities inspected a factory in Belgium that is part of AstraZeneca's vaccine production chain. It followed a crisis meeting the previous evening between EU officials and the company which failed to resolve the issue.
Meanwhile, both AstraZeneca and the UK, which has already been using the vaccine, insist it is efficient in older adults. This follows doubt cast in Germany by the country's vaccination commission which declined to recommend its immediate use for people over 65.
EU to 'explore all options'
In a reply to a letter he received from four European government leaders, EU Council President Charles Michel said the EU "should explore all options and make use of all legal means and enforcement measures at our disposal," if negotiations with drug companies don't yield satisfaction.
AstraZeneca said last week that it planned to cut initial deliveries in the EU from the scheduled 80 million doses for the first quarter of the year to 31 million doses. The company cited reduced yields from its manufacturing plants in Europe, but the EU suspects doses produced in Europe have been directed elsewhere.
Michel said the use of the EU treaties would allow the EU and member states to take "appropriate urgent measures, to ensure effective vaccine production and supply for our population".
The European Commission also plans to new rules strengthening the control of vaccine exports to ensure the doses it bought are delivered to the bloc's residents.
The dispute highlights the tension over vaccine supplies as Europe struggles to roll out inoculation programs against the coronavirus.
AstraZeneca and UK refute German claims
The UK and AstraZeneca hit back on Thursday at the draft recommendation in Germany to restrict the use of the vaccine only to people aged 18-64 for now. The country's vaccination advisory committee cited what it said was insufficient data to judge its effectiveness for older people.
"Our own authorities have made it very clear that they think the Oxford AstraZeneca vaccine is very good and efficacious," said British Prime Minister Boris Johnson. "The evidence that they've seen, that they've supplied, is that they think that it is effective across all age groups and provides a good immune response across all age groups."
"The latest analyses of clinical trial data for the AstraZeneca/Oxford COVID-19 vaccine support efficacy in the over 65 years age group. We await a regulatory decision on the vaccine by the EMA in the coming days," an AstraZeneca spokesperson said.
Germany's health minister has stressed that a final decision will not be made until after Friday's EMA meeting. — Euronews


Clic here to read the story from its source.